Trials / Withdrawn
WithdrawnNCT05266677
DHA Proof-of-Concept Study in Infants and Toddlers
Effect of a Liquid Oral Supplement Comprising a Blend of Glycerides at Certain Proportions on Infant and Toddler DHA Status
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 2 Months – 14 Months
- Healthy volunteers
- Accepted
Summary
This is a prospective, double blind, randomized, controlled proof-of-concept study with a parallel group design that aims to investigate the effect of a liquid oral supplement comprising a blend of glycerides at certain proportions on infant and toddler DHA status.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blend of glycerides at certain proportions | combination of glycerides in specific proportions in a liquid oral supplement |
| OTHER | glycerides used in current formulas | glycerides used in current formulas in a liquid oral supplement |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2023-03-01
- Completion
- 2023-05-01
- First posted
- 2022-03-04
- Last updated
- 2022-07-18
Source: ClinicalTrials.gov record NCT05266677. Inclusion in this directory is not an endorsement.